GlobeNewswire

BNP Paribas Announces Senior Staff Appointments in the USA and the Americas

Dela

NEW YORK, June 14, 2018 (GLOBE NEWSWIRE) -- As BNP Paribas continues to evolve its platform in the region and build on the significant growth to date, as well as reinforce its commitment to clients, it is pleased to announce the appointments of several executive members:

Jean-Yves Fillion: CEO of BNP Paribas USA and CEO of CIB Americas becomes Chairman of CIB Americas and continues to serve as CEO of BNP Paribas USA, BNP Paribas' intermediate holding company that oversees the bank's wholesale and retail activities including Bank of the West and First Hawaiian. In these two roles, Mr. Fillion is responsible for the bank's regional corporate strategy and will sponsor the bank's relationships with the region's most important clients and external stakeholders. Mr. Fillion has been with BNP Paribas for 33 years, 26 of which he has spent in the United States between Chicago, Los Angeles and New York.

Bob Hawley: Deputy CEO CIB Americas becomes CEO of CIB Americas. Reporting to Jean-Yves Fillion regionally and to Yann Gérardin, Head of Corporate and Institutional Banking, globally, Mr. Hawley will continue to serve as Head of the Institutional Platform Americas (which includes Global Markets, Securities Services, and Financial Institutions Client Coverage) and Head of Global Markets Americas. Mr. Hawley will also be responsible for the Brazilian CIB platform. He has been with BNP Paribas since 1997 in increasing roles within CIB in Tokyo, Hong Kong, London and New York.

Pierre Veyres: is appointed Deputy Head of CIB Americas and Head of the Corporate Platform Americas, (which includes Corporate Coverage, Financing Solutions, Credit and Portfolio Management, and Advisory). Reporting to Bob Hawley, Mr. Veyres will be responsible for leading the Group's strategy to grow the corporate franchise and will be a member of the CIB Americas Executive Committee. He will oversee the CIB platforms in Hispanic LATAM and Canada. Mr. Veyres joins the Americas team from APAC, where he has served as the CEO of the BNP Paribas Singapore branch as well as the Head of Territory for Singapore and Head of CIB Southeast Asia since October 2013.

Philippe Ricard: appointed COO CIB Americas. Mr. Ricard, who's been in the region since 2017, is replacing Bruno d'Illiers, who is moving to a new role with the Bank in Paris. In his capacity as COO, CIB Americas, Mr. Ricard will report to Bob Hawley. Mr. Ricard will continue to serve as COO of BNP Paribas USA for which he reports to Mr. Fillion. Since joining the Group in 1989, Mr. Ricard has held a wide range of leadership positions across BNP Paribas' key regions and businesses, most recently as Global Head of Asset and Fund Services within BNP Paribas Securities Services.

Sonja Volpe: Country Head of Canada. Ms. Volpe brings over 17 years of experience covering Canadian financial institutions and public sector clients. She first joined BNP Paribas in 2015 as Head of Financial Institutions Coverage in Canada and has been instrumental in developing the bank's institutional client franchise in the region. She will continue to drive the bank's business growth as well as further develop Canada as an operational platform in the region. With over 800 employees in offices in Montreal and Toronto, Canada plays an important role in the Americas.

Thalès Gabay: appointed Head of ALM Treasury CIB Americas. Mr. Gabay is replacing Jonathan Light who is retiring. Mr. Gabay most recently served as Head of ALMT for APAC, following a successful tenure as Head of ALMT for the Latin America region.

Amanda Rajkumar: appointed Head of Human Resources for BNP Paribas USA and CIB Americas. Ms. Rajkumar brings with her over 25 years' experience in Human Resources within the investment banking arena. She joined BNP Paribas in May 2009 as Head of HR for BNP Paribas Securities Services in the UK, and most recently, she was responsible for Global Markets and Financial Institutions Coverage Human Resources in London and previous to that headed Global Fixed Income Human Resources for 5 years.

Emmanuelle Bury: appointed Chief Conduct and Control Officer (CCCO) for BNP Paribas USA and CIB Americas. Ms. Bury comes from BNP Paribas Paris where she was the Global COO for the ALM Treasury Group. She will be joining the CIB Americas Executive Committee and will ensure that all Conduct & Control matters are well incorporated into the governance and working principles of all business lines.

All appointments are effective in June except: Sonja Volpe, effective July 1; Philippe Ricard, effective August 1; and Pierre Veyres, effective September 1.

Yann Gérardin, Head of Corporate and Institutional Banking, said: "BNP Paribas has experienced solid growth over the past few years, and now, backed by the Bank's commitment to invest substantial capital and resources in our Americas platform we are poised to elevate our business to the next level. A key factor in our success remains our continued focus on our clients: supporting their needs globally and providing them with strategic guidance. To support this mission we are investing in our leadership, which includes these appointments."

Jean-Yves Fillion, CEO of BNP Paribas USA & Chairman of CIB Americas, said of the appointments: "BNP Paribas is at a pivotal moment for the Americas platform. As the competitive landscape evolves, our business is well-positioned to continue our strong progress toward becoming one of the top European banks in the region. We have a tremendous opportunity in front of us in both our wholesale and retail businesses as a unified region with a global offering that differentiates the bank in the marketplace. I am excited for what the bank will achieve in the years ahead."

PRESS CONTACTS
Ilias Catsaros
+1 917 254 6365
ilias.catsaros@us.bnpparibas.com

Mylene Benmoussa
+1 646 322 5221
mylene.benmoussa@us.bnpparibas.com

About BNP Paribas in the USA
BNP Paribas has built a strong and diversified presence in the United States to support its client base. The bank employs over 16,000 people and has had a presence in the USA since the late 1800s. Bank of the West and First Hawaiian Bank (together BancWest, part of Retail Banking & Services) serve nearly 2.5 million individuals and businesses through a network of more than 650 branches and business centers. Large corporate and institutional clients are serviced by BNP Paribas' Corporate & Institutional Banking franchise that has a presence in the main US cities, in addition to a global reach through a network of offices in EMEA and APAC. The bank also offers asset management services through BNP Paribas Asset Management (part of Retail Banking & Services) as well as Real Estate and Fleet Services through partnerships. www.usa.bnpparibas.

About BNP Paribas 
BNP Paribas is a leading bank in Europe with an international reach. It has a presence in 73 countries, with more than 196,000 employees, including more than 149,000 in Europe. The Group has key positions in its three main activities: Domestic Markets and International Financial Services (whose retail banking networks and financial services are covered by Retail Banking & Services) and Corporate & Institutional Banking, which serves two client franchises: corporate clients and institutional investors. The Group helps all its clients (individuals, community associations, entrepreneurs, SMEs, corporate and institutional clients) to realize their projects through solutions spanning financing, investment, savings and protection insurance. In Europe, the Group has four domestic markets (Belgium, France, Italy and Luxembourg) and BNP Paribas Personal Finance is the European leader in consumer lending. BNP Paribas is rolling out its integrated retail banking model in Mediterranean countries, in Turkey, in Eastern Europe and a large network in the western part of the United States. In its Corporate & Institutional Banking and International Financial Services activities, BNP Paribas also enjoys top positions in Europe, a strong presence in the Americas as well as a solid and fast-growing business in Asia-Pacific.                           




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: BNP Paribas Securities Corp. via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Arcoma AB: Investerarmöten våren 201915.2.2019 08:46:00Pressmeddelande

15 februari 2019 PRESSRELEASE Arcoma har som ambition att fortsätta öka sitt aktieägarfokus och kontinuerligt förbättra kommunikationen med aktieägare. Under våren 2019 kommer Arcoma medverka på flertalet investerarmöten där aktuella händelser och aktiviteter presenteras. Här ges en ökad inblick i bolagets vision och strategier samt en möjlighet till att ställa frågor till bolagets ledning. SvD Börsplus Temadag "Dubblare" Dag, tid och plats: 5 mars, kl. 13.00, GT 30, Grev Turegatan 30, Stockholm Stockholm Corporate Finance Life Science event Dag, tid och plats: 14 mars, kl. 07.30, Berns, Kammarsalen, Stockholm Redeyes Medtech & Diagnostics event Dag, tid och plats: 14:e maj, Redeye, Mäster Samuelsgatan 42, Stockholm För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soderqvist at arcoma.se Om Arcoma Arcoma, med lång erfarenhet av branschen, är en ledande leverantör av integrerade digitala röntgensystem med hög kvalite

Corline Biomedical AB: Första patient doserad med Renaparin®15.2.2019 08:42:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man inkluderat första patienten i fas 1-studien RENAPAIR 01. Patienten inkluderades vid transplantationsavdelningen på Uppsala Akademiska sjukhus. Renaparin® är en produkt under utveckling för att förbättra njurtransplantation. I Corlines studie RENAPAIR 01 utvärderas produkten med avseende på tolerabilitet och säkerhet. Studien öppnades för patientrekrytering i slutet av 2018 och första patient är nu doserad och inkluderad i studien. Totalt skall 18 patienter rekryteras och när de 4 första patienterna är utvärderade i Uppsala, öppnas också Karolinska Universitetssjukhuset i Huddinge för rekrytering till studien. Henrik Nittmar, VD i Corline Biomedical AB, kommenterar "Det händer mycket i Corline för tillfället och alla arbetar hårt för att målbilden i bolaget skall uppfyllas. Det gäller såväl vår interna organisation som våra externa samarbetspartners. Därför är det extra roligt när vi når avgörande milstolpar i utvec

Corline Biomedical AB: Rekryterar Lars Olsson som Head of CMC14.2.2019 12:44:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man rekryterat Lars Olsson till den nyinrättade tjänsten som Head of CMC (Chemistry, Manufacturing & Control). Lars Olsson hade tidigare samma tjänst hos Wilson Therapeutics AB, som under 2018 förvärvades av amerikanska Alexion. Lars Olsson kommer att ansvara för Corlines samtliga aktiviteter inom tillverkning och kontroll relaterat till bolagets läkemedelsprodukter, med särskilt fokus på Renaparin® inför kommande fas 2- och fas 3-utveckling. I slutet av 2018 meddelade Corline att patientrekryteringen startar i bolagets fas 1-studie RENAPAIR 01, där produkten Renaparin®, som är under utveckling för att förbättra utfallet av njurtransplantation, utvärderas med avseende på tolerabilitet och säkerhet. Därmed tog en ny utvecklingsfas vid i bolaget i vilken alltmer resurser fokuseras på att förbereda den fortsatta kliniska utvecklingen av produkten genom fas 2 och fas 3 i syfte att slutligen kunna registrera produkten för k

Arcoma AB: Canon och Arcoma tecknar distributörsavtal för Turkiet14.2.2019 10:38:00Pressmeddelande

14 februari 2019 Canon Medical Systems i Turkiet och Arcoma har tecknat ett distributörsavtal som gör att Canon kommer att kunna sälja Arcomas produkter i Turkiet från och med den 15 februari 2019. Canon är sedan tidigare återförsäljare för Arcomas produkter i Nordamerika och utvalda länder i Europa. Detta samarbete utökas nu till Turkiet som är det första land i Canons Asien organisation att välja Arcoma som en formell partner. "Att vi stärker och formaliserar samarbetet med Canon även i Turkiet är ännu ett erkännande av Arcoma som leverantör av högkvalitativa röntgensystem. Canon i Turkiet förbereder ett flertal större upphandlingar till sjukhus där Arcomas lösningar ingår. Avtal som detta ingår i Arcomas strategi att utöka med nya försäljningskanaler och att expandera till nya länder för att skapa framtida tillväxt." kommenterar Arcomas VD, Jesper Söderqvist. För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soder

Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North12.2.2019 09:00:00Pressmeddelande

STOCKHOLM, February 12, 2019. Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million. Swedish private investors and the French investment management company Alto Invest have taken part in the private placement. OssDsign will now begin the process towards a listing on Nasdaq First North in 2019. The proceeds from the private placement will be used for continued sales expansion in Europe and the US of OssDsign regenerative implant solutions for improved healing of bone defects. Moreover, funds will be used for entering new markets, primarily preparing for market introduction in Japan where the company in parallel to the regulatory process will initiate pre marketing activities. With ethical committee approval already in place, leading surgeons in Japan can start building experience with the OssDsign technology prior to regulatory approval and launch. OssDsign prepares for a listing on Nasdaq Stockholm First North in 2019.

Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North12.2.2019 09:00:00Pressmeddelande

STOCKHOLM, February 12, 2019. Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million. Swedish private investors and the French investment management company Alto Invest have taken part in the private placement. OssDsign will now begin the process towards a listing on Nasdaq First North in 2019. The proceeds from the private placement will be used for continued sales expansion in Europe and the US of OssDsign regenerative implant solutions for improved healing of bone defects. Moreover, funds will be used for entering new markets, primarily preparing for market introduction in Japan where the company in parallel to the regulatory process will initiate pre marketing activities. With ethical committee approval already in place, leading surgeons in Japan can start building experience with the OssDsign technology prior to regulatory approval and launch. OssDsign prepares for a listing on Nasdaq Stockholm First North in 2019.

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum